Skip to content

HHRI News & Press Releases

HHRI News & Press Releases

Dr. Burrack Lab Photo

Dr. Burrack Bound for Homeward Bound

April 24, 2023

Growing up, Kristina Burrack, PhD, was always on the move. She was fascinated by the outdoors, loved hands-on learning, and played college athletics. Dr. Burrack loved doing science labs and knew she wanted to be a biology major in college. While at St. Olaf College, she became passionate about immunology…

Read More

STIs, HIV Prevention

April 24, 2023

Our Research Home » Our Research » Protected: STIs, HIV Prevention STIs, HIV Prevention, Clinical Trials, Behavioral Science   Jenell Stewart, DO, MPH, is an Infectious Diseases physician-scientist focused on the prevention of Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) and improving clinical care for women who engage in…

Read More
Doxycycline

Doxycycline does not prevent STIs among cisgender women

February 20, 2023

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women. The dPEP…

Read More

HHRI investigators highlighted by CTSI as UMN Mothers Leading Science

January 26, 2023

Hennepin Healthcare Research Institute (HHRI) investigators Anne Frosch, MD, MPH, and Sandra Japuntich, PhD, LP, were featured in the University of Minnesota’s Clinical & Translational Science Institute (CTSI) news welcoming the fourth cohort of researcher-moms into Mothers Leading Science, a yearlong career development program for research-intensive faculty in the health sciences…

Read More

Thank you to Dr. Jason Baker for his exceptional dedication and service as HHRI Vice President

January 27, 2022

Jason Baker, MD, MS, recently stepped down as Vice President of Hennepin Healthcare Research Institute (HHRI). Dr. Baker began his tenure as VP in January 2015 when the institute was the Minneapolis Medical Research Foundation and served in the role until December 2021. During this time, Dr. Baker was instrumental…

Read More

Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19

April 9, 2020

Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.  Hennepin Healthcare is a clinical site…

Read More
input search string and hit enter